Immune Response to Hepatitis B Virus Proteins: Relevance of the Murine Model

No abstract is available for this paper.

• Publication year

  1991

• Venue

  Seminars in liver disease (Print)

• Publication date

  1991-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1055/s-2008-1040428PMID 1832237
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Albumin receptors on hepatitis B virus and antibodies to albumin.

  2008cited by this paper
• Transplacental transmission of hepatitis 'B' virus.

  1992cited by this paper
• Hepatitis B Virus Mutants with Precore-Region Defects in Two Babies with Fulminant Hepatitis and Their Mothers Positive for Antibody to Hepatitis B e Antigen

  1991cited by this paper
• Hepatitis B virus core antigen has two nuclear localization sequences in the arginine-rich carboxyl terminus

  1991cited by this paper
• Importance of subtype in the immune response to the pre-S(2) region of the hepatitis B surface antigen. I. T cell fine specificity.

  1990cited by this paper
• Protective efficacy of a novel hepatitis B vaccine consisting of M (pre-S2 + S) protein particles (a third generation vaccine).

  1990cited by this paper
• Cellular immune response to hepatitis B virus-encoded antigens in acute and chronic hepatitis B virus infection.

  1990cited by this paper
• Active hepatitis B virus replication in the presence of anti-HBe is associated with viral variants containing an inactive pre-C region.

  1990cited by this paper
• Hepatitis B viruses with precore region defects prevail in persistently infected hosts along with seroconversion to the antibody against e antigen

  1990cited by this paper
• Seminars in Liver Disease: volume 10.

  1990cited by this paper
• A new hepatitis B virus variant in a chronic carrier with multiple episodes of viral reactivation and acute hepatitis.

  1990cited by this paper
• Selective killing of hepatitis B envelope antigen-specific B cells by class I-restricted, exogenous antigen-specific T lymphocytes

  1990cited by this paper
• Immunobiology and pathogenesis of hepatocellular injury in hepatitis B virus transgenic mice.

  1990cited by this paper
• In vitro immune responses to hepatitis B surface antigens S and preS2 during acute infection by hepatitis B virus in humans.

  1990cited by this paper
• Presentation and immunogenicity of viral epitopes on the surface of hybrid hepatitis B virus core particles produced in bacteria.

  1990cited by this paper
• Interaction between hepatitis B surface proteins and monomeric human serum albumin

  1990cited by this paper
• Molecular characterization of a new variant of hepatitis b virus in a persistently infected homosexual man

  1990cited by this paper
• Fine specificity of human antibody response to the pres1 domain of hepatitis B virus

  1990cited by this paper
• Is a function of the secreted hepatitis B e antigen to induce immunologic tolerance in utero?

  1990cited by this paper
• Importance of subtype in the immune response to the pre-S(2) region of the hepatitis B surface antigen. II. Synthetic Pre-S(2) immunogen.

  1990cited by this paper
• A new hepatitis B virus strain in patients with severe anti-HBe positive chronic hepatitis B.

  1990cited by this paper
• Maternal hepatitis B virus DNA in mother-infant transmission.

  1989cited by this paper
• Hepatitis B core antigen-specific IFN-gamma production of peripheral blood mononuclear cells in patients with chronic hepatitis B virus infection.

  1989cited by this paper
• Prevalence of hepatitis B surface antigen in pregnant mothers and its perinatal transmission.

  1989cited by this paper
• Protective effect of a synthetic peptide comprising the complete pres2 region of the hepatitis b virus surface protein

  1989cited by this paper
• Detection of antibodies against hepatitis B virus polymerase antigen in hepatitis B virus‐infected patients

  1989cited by this paper
• Mutation preventing formation of hepatitis B e antigen in patients with chronic hepatitis B infection.

  1989cited by this paper
• The secretory core protein of human hepatitis B virus is expressed on the cell surface

  1989cited by this paper
• MATERNAL HEPATITIS B VIRUS DNA IN MOTHER-INFANT TRANSMISSION

  1989cited by this paper
• Identification of HBV variants which cannot produce pre-core derived HBeAg and may be responsible for severe hepatitis

  1989cited by this paper
• Recognition of hepatitis B virus envelope proteins by liver-infiltrating T lymphocytes in chronic HBV infection.

  1989cited by this paper
• The preS1 antigen of hepatitis B virus is highly immunogenic at the T cell level in man.

  1989cited by this paper
• Distinction between immunogenicity and tolerogenicity among HBcAg T cell determinants. Influence of peptide-MHC interaction.

  1989cited by this paper
• Genetic prediction of nonresponse to hepatitis B vaccine.

  1989cited by this paper
• Protective efficacy of a recombinant DNA hepatitis B vaccine in neonates of HBe antigen-positive mothers.

  1989cited by this paper
• Randomized dose range study of a recombinant hepatitis B vaccine produced in mammalian cells and containing the S and PreS2 sequences.

  1989cited by this paper
• Immunogenicity of human hepatitis B virus P-gene derived proteins.

  1989cited by this paper
• Neonatal thymectomy results in a repertoire enriched in T cells deleted in adult thymus.

  1989cited by this paper
• Anti-pre-S2 antibodies in natural hepatitis B virus infection and after immunization.

  1988cited by this paper
• Hepatitis B synthetic immunogen comprised of nucleocapsid T-cell sites and an envelope B-cell epitope.

  1988cited by this paper
• T- and B-cell recognition of hepatitis B viral antigens.

  1988cited by this paper
• Comparative immunogenicity of hepatitis B virus core and E antigens.

  1988cited by this paper
• Virus-Host Interaction in Chronic Hepatitis B Virus Infection

  1988cited by this paper
• Recognition of hepatitis B surface antigen by human T lymphocytes. Proliferative and cytotoxic responses to a major antigenic determinant defined by synthetic peptides.

  1988cited by this paper
• Human T cell response to the surface antigen of hepatitis B virus (HBsAg). Endosomal and nonendosomal processing pathways are accessible to both endogenous and exogenous antigen

  1988cited by this paper
• Presence of antibodies to the polymerase gene product(s) of hepatitis B and woodchuck hepatitis virus in natural and experimental infections

  1988cited by this paper
• A signal peptide encoded within the precore region of hepatitis B virus directs the secretion of a heterogeneous population of e antigens in Xenopus oocytes.

  1988cited by this paper
• Cytotoxic T-cell responses to the nucleocapsid proteins of HBV in chronic hepatitis. Evidence that antibody modulation may cause protracted infection.

  1987cited by this paper
• Genetic and Molecular Basis for T‐ and B‐Cell Recognition of Hepatitis B Viral Antigens

  1987cited by this paper
• Improved immunogenicity of a peptide epitope after fusion to hepatitis B core protein

  1987cited by this paper
• Cellular immunity to nucleocapsid and pre-S determinants in asymptomatic carriers of hepatitis B virus.

  1987cited by this paper
• Antibody production to the nucleocapsid and envelope of the hepatitis B virus primed by a single synthetic T cell site

  1987cited by this paper
• Detection of antibodies against pre-S1 proteins in sera of patients with hepatitis B virus (HBV) infection.

  1987cited by this paper
• Intrahepatic, nucleocapsid antigen-specific T cells in chronic active hepatitis B.

  1987cited by this paper
• Immune response to hepatitis B virus core antigen (HBcAg): localization of T cell recognition sites within HBcAg/HBeAg.

  1987cited by this paper
• Immunological cross-reactivity between preS2 sequences of the hepatitis B virus envelope proteins corresponding to serological subtypes adw2 and ayw.

  1987cited by this paper
• Definition of hepatitis B virus (HBV)-specific target antigens recognized by cytotoxic T cells in acute HBV infection.

  1987cited by this paper
• Protective immunisation against hepatitis B with an internal antigen of the virus

  1987cited by this paper
• Antibodies to synthetic peptides from the pre-S1 and pre-S2 regions of one subtype of the hepatitis B virus (HBV) envelope protein recognize all HBV subtypes.

  1987cited by this paper
• Functional characterization of cloned intrahepatic, hepatitis B virus nucleoprotein-specific helper T cell lines.

  1987cited by this paper
• A single 10-residue pre-S(1) peptide can prime T cell help for antibody production to multiple epitopes within the pre-S(1), pre-S(2), and S regions of HBsAg.

  1987cited by this paper
• Characterization of cell mediated immune responses to the hepatitis B core protein in man.

  1987cited by this paper
• A synthetic peptide vaccine involving the product of the pre-S(2) region of hepatitis B virus DNA: protective efficacy in chimpanzees.

  1986cited by this paper
• Impaired antibody synthesis in patients with chronic hepatitis B infection

  1986cited by this paper
• The nucleocapsid of hepatitis B virus is both a T-cell-independent and a T-cell-dependent antigen.

  1986cited by this paper
• Hepatitis B surface antigen: an unusual secreted protein initially synthesized as a transmembrane polypeptide

  1986cited by this paper
• Antibody to the receptor for polymerized human serum albumin in acute and persistent infection with hepatitis B virus

  1986cited by this paper
• Antibodies to pre-S and X determinants arise during natural infection with ground squirrel hepatitis virus

  1986cited by this paper
• Transplacental transmission of hepatitis B virus.

  1986cited by this paper
• Immunochemical structure of the hepatitis B surface antigen vaccine--II. Analysis of antibody responses in human sera against the envelope proteins.

  1986cited by this paper
• Pre-S1 antigens and antibodies early in the course of acute hepatitis B virus infection

  1986cited by this paper
• Absence of pre-S2 antibodies in natural hepatitis B virus infection.

  1986cited by this paper
• Nonresponsiveness to hepatitis B vaccine in health care workers. Results of revaccination and genetic typings.

  1986cited by this paper
• Antibodies to a synthetic peptide from the preS 120-145 region of the hepatitis B virus envelope are virus neutralizing.

  1986cited by this paper
• A solid-phase enzyme immunoassay for the determination of IgM and IgG antibodies against translation products of pre-S1 and pre-S2 regions of hepatitis B virus.

  1986cited by this paper
• Immune response to the pre-S(1) region of the hepatitis B surface antigen (HBsAg): a pre-S(1)-specific T cell response can bypass nonresponsiveness to the pre-S(2) and S regions of HBsAg.

  1986cited by this paper
• Two distinct but overlapping antibody binding sites in the pre-S(2) region of HBsAg localized within 11 continuous residues.

  1986cited by this paper
• Prevention of maternal‐infant hepatitis B virus transmission by immunization: The role of serum hepatitis B virus DNA

  1986cited by this paper
• Hepatitis B virus pre‐S gene‐encoded antigenic specificity and anti‐pre‐S antibody: Relationship between anti‐pre‐S response and recovery

  1986cited by this paper
• Selective sensitization of peripheral blood T lymphocytes to hepatitis B core antigen in patients with chronic active hepatitis type B.

  1986cited by this paper
• Hepatitis B vaccine with and without polymerised albumin receptors.

  1985cited by this paper
• T lymphocyte sensitization to hbcag and T cell‐mediated unresponsiveness to HBsAg in hepatitis B virus‐related chronic liver disease

  1985cited by this paper
• Distinct H-2-linked regulation of T-cell responses to the pre-S and S regions of the same hepatitis B surface antigen polypeptide allows circumvention of nonresponsiveness to the S region.

  1985cited by this paper
• Hepatitis B virus contains pre-S gene-encoded domains

  1985cited by this paper
• Antibodies to peptides detect new hepatitis B antigen: serological correlation with hepatocellular carcinoma.

  1985cited by this paper
• Genetic regulation of the immune response to hepatitis B surface antigen (HBsAg). V. T cell proliferative response and cellular interactions.

  1985cited by this paper
• Hemagglutination assay of polypeptide coded by the pre-S region of hepatitis B virus DNA with monoclonal antibody: correlation of pre-S polypeptide with the receptor for polymerized human serum albumin in serums containing hepatitis B antigens.

  1985cited by this paper
• Interaction between various polymerized human albumins and hepatitis B surface antigen

  1985cited by this paper
• Enhanced immunogenicity of the pre-S region of hepatitis B surface antigen.

  1985cited by this paper
• Location and chemical synthesis of a pre-S gene coded immunodominant epitope of hepatitis B virus.

  1984cited by this paper
• Large surface proteins of hepatitis B virus containing the pre-s sequence

  1984cited by this paper
• A polypeptide containing 55 amino acid residues coded by the pre-S region of hepatitis B virus deoxyribonucleic acid bears the receptor for polymerized human as well as chimpanzee albumins.

  1984cited by this paper
• Hepatitis B virus-reactive human T lymphocyte clones: antigen specificity and helper function for antibody synthesis.

  1984cited by this paper
• Genetic regulation of the immune response to hepatitis B surface antigen (HBsAg). IV. Distinct H-2-linked Ir genes control antibody responses to different HBsAg determinants on the same molecule and map to the I-A and I-C subregions

  1984cited by this paper
• Possible role of immune responses to hepatitis B core antigen in protection against hepatitis B infections.

  1984cited by this paper
• Hepatitis B virus antigens made in microbial cells immunise against viral infection.

  1984cited by this paper
• An Antibody Which Precipitates Dane Particles in Acute Hepatitis Type B: Relation to Receptor Sites Which Bind Polymerized Human Serum Albumin on Virus Particles

  1984cited by this paper
• A hepatitis B surface antigen polypeptide (P31) with the receptor for polymerized human as well as chimpanzee albumins.

  1983cited by this paper
• Postnatal infectivity of hepatitis B surface antigen-carrier mothers.

  1983cited by this paper
• Lack of anti-HBc IgM in neonates with HBsAg carrier mothers argues against transplacental transmission of hepatitis B virus infection.

  1983cited by this paper

• Circulation of hepatitis delta virus and occult hepatitis B virus infection amongst HIV/HBV co-infected patients in Korle-Bu, Ghana

  2021cites this paper
• The immune response of rhesus macaques to novel vaccines comprising hepatitis B virus S, PreS1, and Core antigens.

  2018cites this paper
• CO-RRELATATION OF ALT & AST LEVELS WITH HEPATITIS B VIRUS DNA VIRAL LOAD

  2018cites this paper
• Vaccines targeting preS1 domain overcome immune tolerance in hepatitis B virus carrier mice

  2017influential citation
• Distribution of serological screening markers at a large hematology and hemotherapy center in Minas Gerais, Southeastern Brazil

  2016cites this paper
• High-Throughput Analysis of the T Cell Receptor Beta Chain Repertoire in PBMCs from Chronic Hepatitis B Patients with HBeAg Seroconversion

  2016cites this paper
• Parenteral delivery of the vaccine candidate TERAVAC-HIV-1 bypasses pre-existing immune response to the hepatitis B virus antigens in mice

  2015cites this paper
• La administración parenteral del candidato vacunal TERAVAC-HIV-1 no es interferida por la respuesta inmune previa contra antígenos del virus de la hepatitis B en ratones

  2015cites this paper
• Clinical significance of serum hepatocyte growth factor (HGF) levels in hepatocellular carcinoma

  2014cites this paper
• The natural course of chronic hepatitis B virus infection and its management.

  2013cites this paper
• Purification and Characterization of a Naturally Processed Hepatitis B Virus Peptide Recognized by CD 8 1 Cytotoxic T Lymphocytes

  2013cites this paper
• Human genetics and respiratory syncytial virus disease: current findings and future approaches.

  2013cites this paper
• Perspectives for a Vaccine against Hepatitis Delta Virus

  2012cites this paper
• Revised cutoff values of ALT and HBV DNA level can better differentiate HBeAg (-) chronic inactive HBV patients from active carriers

  2011cites this paper
• Milestones and perspectives in viral hepatitis B

  2011cites this paper
• Natural history of chronic hepatitis B in Euro-Mediterranean and African countries.

  2011cites this paper
• Lower baseline ALT cut-off values and HBV DNA levels better differentiate HBeAg- chronic hepatitis B patients from inactive chronic carriers.

  2009cites this paper
• Anti-HIV-1 and anti-HBV immune responses in mice after parenteral and nasal co-administration of a multiantigenic formulation.

  2008cites this paper
• Identification of novel HLA-DR1-restricted epitopes from the hepatitis B virus envelope protein in mice expressing HLA-DR1 and vaccinated human subjects.

  2006cites this paper
• Coinoculation with hepatitis B surface and core antigen promotes a Th1 immune response to a multiepitopic protein of HIV‐1

  2006cites this paper
• A randomized, controlled, clinical study of thymosin alpha-1 versus interferon-alpha in [corrected] patients with chronic hepatitis B lacking HBeAg in China [corrected].

  2005cites this paper
• A Randomized, Controlled, Clinical Study of Thymosin Alpha‐1 Versus Interferon‐Alpha in Chinese Patients with Chronic Hepatitis B Lacking Hepatitis B Envelope Antigen

  2005cites this paper
• [Hepatitis B and C serologic markers in blood donors of the Ribeirão Preto Blood Center].

  2005cites this paper
• Molecular analysis of HLA class II associations with hepatitis B virus clearance and vaccine nonresponsiveness

  2005cites this paper
• Marcadores sorológicos das hepatites B e C em doadores de sangue do Hemocentro de Ribeirão Preto, SP

  2005cites this paper
• Genetic Variation in Host Defenses and Viral Infections

  2005cites this paper
• Hepatitis B Virus Vaccine Response in Children 15–19 Years Old

  2005cites this paper
• A one-filter-three-probe assay for defective interference (DI) effects of naturally occurring core internal deletion (CID) variants of human hepatitis B virus.

  2004cites this paper
• 17. CURRENT ISSUES IN HEPATITIS B VACCINES

  2004cites this paper
• A mouse model of human adaptive immune functions: HLA‐A2.1‐/HLA‐DR1‐transgenic H‐2 class I‐/class II‐knockout mice

  2004cites this paper
• Significance of hepatitis B viremia levels determined by a quantitative polymerase chain reaction assay in patients with hepatitis B e antigen–negative chronic hepatitis B virus infection

  2003cites this paper
• Molecular epidemiology and transmission of hepatitis B virus in close family contacts of HBV‐related chronic liver disease patients

  2003cites this paper
• Mannose-binding lectin gene polymorphisms and hepatitis B virus infection in Vietnamese patients.

  2003cites this paper
• Serum cytokine profiles associated with clinical presentation in Vietnamese infected with hepatitis B virus.

  2003cites this paper
• Immunogenicity of recombinant HBsAg/HCV particles in mice pre-immunised with hepatitis B virus-specific vaccine.

  2003cites this paper
• Recombinant hepatitis B triple antigen vaccine: Hepacare®

  2002cites this paper
• CpG Oligodeoxynucleotides with Hepatitis B Surface Antigen (HBsAg) for Vaccination in HBsAg-Transgenic Mice

  2001cites this paper
• Activation‐induced cell death in peripheral blood mononuclear cells (PBMCs) from patients with chronic hepatitis B may be related to abnormal production of interleukin 12 and 10

  2001cites this paper
• Activation-induced cell death in peripheral blood mononuclear cells (PBMCs) from patients with chronic hepatitis B may be related to abnormal production of interleukin 12 and 10.

  2001cites this paper
• Preliminary results of Thymosin-a1 vs interferon-α treatment in patients with HBeAg negative and serum HBV DNA positive chronic hepatitis B

  2001cites this paper
• Randomized controlled clinical trial on the treatment of Thymosin-a1 vs interferon-α in patients with hepatitis B

  2001cites this paper
• Preliminary results of Thymosin-a1 versus interferon-alpha-treatment in patients with HBeAg negative and serum HBV DNA positive chronic hepatitis B.

  2001cites this paper
• A Novel, Recombinant Triple Antigen Hepatitis B Vaccine (Hepacare®)

  2001cites this paper
• A randomized controlled clinical trial on the treatment of Thymosin a1 versus interferon-alpha in patients with hepatitis B.

  2001cites this paper
• Host-pathogen interactions in emerging and re-emerging infectious diseases: a genomic perspective of tuberculosis, malaria, human immunodeficiency virus infection, hepatitis B, and cholera.

  2000cites this paper
• Immunological characterization of two major secreted forms of recombinant hepatitis B virus e antigens.

  1999cites this paper
• T-cell and antibody response characterisation of a new recombinant pre-S1, pre-S2 and SHBs antigen-containing hepatitis B vaccine; demonstration of superior anti-SHBs antibody induction in responder mice.

  1999cites this paper
• An analysis of T cell antigen receptor variable beta genes during the clinical course of patients with chronic hepatitis B.

  1999cites this paper
• An analysis of T cell antigen receptor variable β genes during the clinical course of patients with chronic hepatitis B

  1999cites this paper
• Efficacy of thymosin α1 in patients with chronic hepatitis B: A randomized, controlled trial

  1998cites this paper
• Hepatitis B third‐generation vaccines: improved response and conventional vaccine non‐response – third generation pre‐S/S vaccines overcome non‐response

  1998cites this paper
• Identification of autoantigen epitopes in MHC Class II transgenic mice

  1998cites this paper
• Interferon treatment in hepatitis B surface antigen‐positive hepatitis B e antibody‐positive chronic hepatitis B: role of hepatitis B core antibody IgM titre in patient selection and treatment monitoring

  1998cites this paper
• Efficacy of thymosin alpha1 in patients with chronic hepatitis B: a randomized, controlled trial.

  1998cites this paper
• Characterization of the T‐ and B‐cell immune response to a new recombinant pre‐S1, pre‐S2 and SHBs antigen containing hepatitis B vaccine (Hepagene™); evidence for superior anti‐SHBs antibody induction in responder mice

  1998cites this paper
• Analysis of Human T-Cell Antigen Receptor Variable β Gene Usage Following Vaccination with Recombinant HBsAg

  1998cites this paper
• Pre‐S2 defective hepatitis B virus infection in patients with fulminant hepatitis

  1997cites this paper
• Association between frequency of amino acid changes in core region of hepatitis B virus (HBV) and the presence of precore mutation in Japanese HBV carriers

  1997cites this paper
• Contribution of human leukocyte antigens to the antibody response to hepatitis B vaccination.

  1997cites this paper
• Nonresponse to hepatitis B vaccines and the kinetics of anti‐HBs production

  1996cites this paper
• Effect of hepatocyte proliferation and cellular DNA synthesis on hepatitis B virus replication.

  1996cites this paper
• Therapy for chronic hepatitis B infection.

  1996cites this paper
• Anergic TH1 clones specific for hepatitis B virus (HBV) core peptides are inhibitory to other HBV core-specific CD4+ T cells in vitro

  1996cites this paper
• Cytokine inhibition of the hepatitis B virus core promoter

  1996cites this paper
• Antiviral Chemotherapy 4

  1996cites this paper
• Purification and characterization of a naturally processed hepatitis B virus peptide recognized by CD8+ cytotoxic T lymphocytes.

  1996cites this paper
• Purification and Characterization of a Naturally Processed Hepatitis B Virus Peptide Recognized by CD8 (cid:49) Cytotoxic T Lymphocytes

  1996influential citation
• Core antigen mutations of human hepatitis B virus in hepatomas accumulate in MHC class II-restricted T cell epitopes.

  1995cites this paper
• Clinical relevance of mutations in the precore genome of the hepatitis B virus.

  1995cites this paper
• Naturally occurring hepatitis B virus core gene mutations

  1995cites this paper
• Activation of a heterogeneous hepatitis B (HB) core and e antigen-specific CD4+ T-cell population during seroconversion to anti-HBe and anti-HBs in hepatitis B virus infection

  1995cites this paper
• Immunization against hepatitis B through adoptive transfer of immunity.

  1995cites this paper
• Viral Hepatitis in Children

  1994cites this paper
• New approaches to the treatment of chronic viral hepatitis B and C.

  1994cites this paper
• Prospectives on the treatment of chronic hepatitis B and chronic hepatitis C with thymic peptides and antiviral agents.

  1994cites this paper
• Hepatitis B virus infection, the immune response and hepatocellular carcinoma.

  1994cites this paper
• Variable Region Usage in T Lymphocytes Infiltrating Liver Tissues of Chronic Liver Diseases

  1994cites this paper
• Correlation between in vivo humoral and in vitro cellular immune responses following immunization with hepatitis B surface antigen (HBsAg) vaccines.

  1994cites this paper
• Intrahepatic mononuclear cell populations and MHC antigen expression in patients with chronic hepatitis C [correction of B]: effect of interferon-alpha.

  1994cites this paper
• Hepatitis B Virus Precore Mutants

  1994cites this paper
• Intrahepatic mononuclear cell populations and MHC antigen expression in patients with chronic hepatitis B: Effect of interferon-α

  1994cites this paper
• Southern‐blot analysis and simultaneous In Situ detection of hepatitis B virus–associated DNA and antigens in patients with end‐stage liver disease

  1993cites this paper
• In vitro potency assays for nonreplicating veterinary vaccines: comparison to in vivo assays and considerations in assay development.

  1993cites this paper
• Role of T-cell tolerance in the persistence of hepatitis B virus infection.

  1993cites this paper
• The serology of chronic hepatitis B infection revisited.

  1993cites this paper
• Ablation of persistent hepatitis B by bone marrow transplantation from a hepatitis B-immune donor.

  1993cites this paper
• Hepatitis B virus heterogeneity, one of many factors influencing the severity of hepatitis B.

  1993cites this paper
• Nosography and immunopathogenesis of viral hepatitis.

  1992cites this paper
• Treatment of chronic hepatitis.

  1992cites this paper
• Chronic Hepatitis and Cirrhosis

  1992cites this paper
• The immune response in chronic hepatitis B virus infection: The “Core” of the problem?

  1992cites this paper
• Acute exacerbations of chronic type B hepatitis are accompanied by increased T cell responses to hepatitis B core and e antigens. Implications for hepatitis B e antigen seroconversion.

  1992cites this paper